| |
|
Form Serial Number: |
DA20230222E00032
|
| 1.
Date of relevant event: |
20/02/2023
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02179 |
| 4.
Name of listed corporation: |
Jiangsu Recbio Technology Co., Ltd. - B - H Shares |
| 5.
Class of shares: |
Domestic Shares |
| 6.
Number of issued shares in class: |
154,824,311 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
LIU |
| (Other names) |
YONG |
|
|
|
| 10.
Name of director (Chinese): |
刘勇 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1113 | The number of shares in which you are interested has increased because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
|
|
24,235,359 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 96,941,440 | 25.69 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 72,706,081 | 46.96 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Taizhou Yuangong Technology Partnership (Limited Partnership) (泰州元工科技合夥企業(有限合夥)) | Room A215, Vaccine Engineering Center, Lujia Road West and Binhai Road North, Taizhou City, the People's Republic of China (中國泰州市陆家路西側、濱河路北側疫苗工程中心A215室) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
| Taizhou Baibei Biology Technology Partnership (Limited Partnership) (泰州百倍生物科技合夥企業(有限合夥)) | Room A213, Vaccine Engineering Center, Lujia Road West and Binhai Road North, Taizhou City, the People's Republic of China (中國泰州市陸家路西側、濱河路北側疫苗工程中心A213室) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
| Taizhou Guquan Biology Technology Partnership (Limited Partnership) (泰州古泉生物科技合夥企業(有限合夥)) | Room A214, Vaccine Engineering Center, Lujia Road West and Binhai Road North, Taizhou City, the People's Republic of China (中國泰州市陸家路西側、濱河路北側疫苗工程中心A214室) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
| Lianyungang Ruibaitai Medical Technology Partnership (Limited Partnership) (連雲港瑞百泰醫藥科技合夥企業(有限合夥)) | 088 Longjizhen Street, Guanyun Country, Lianyuguang City, the People's Republic of China (中國連雲港市灌雲縣龍苴鎮中大街088號) (People's Republic of China) | LIU Yong (as general partner) | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Jiangsu Recbio Technology Co., Ltd. (the "Company") completed the conversion of its 222,498,569 unlisted domestic shares into its H shares (the "Conversion"), and the 24,235,359 unlisted domestic shares held by Mr. LIU Yong (including the corporations in column 30) were converted to H shares. The percentage level of interests in the domestic shares has increased due to the change in the number of the total issued domestic shares under the Conversion.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
22/02/2023
(dd/mm/yyyy)
|
| |